Skip to main content

Advertisement

Log in

Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature

  • Magnetic Resonance
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Purpose

This study was conducted in order to investigate the value of magnetic resonance imaging (MRI)-based radiomics signatures for the preoperative prediction of hepatocellular carcinoma (HCC) grade.

Methods

Data from 170 patients confirmed to have HCC by surgical pathology were divided into a training group (n = 125) and a test group (n = 45). The radiomics features of tumours based on both T1-weighted imaging (WI) and T2WI were extracted by using Matrix Laboratory (MATLAB), and radiomics signatures were generated using the least absolute shrinkage and selection operator (LASSO) logistic regression model. The predicted values of pathological HCC grades using radiomics signatures, clinical factors (including age, sex, tumour size, alpha fetoprotein (AFP) level, history of hepatitis B, hepatocirrhosis, portal vein tumour thrombosis, portal hypertension and pseudocapsule) and the combined models were assessed.

Results

Radiomics signatures could successfully categorise high-grade and low-grade HCC cases (p < 0.05) in both the training and test datasets. Regarding the performances of clinical factors, radiomics signatures and the combined clinical and radiomics signature (from the combined T1WI and T2WI images) models for HCC grading prediction, the areas under the curve (AUCs) were 0.600, 0.742 and 0.800 in the test datasets, respectively. Both the AFP level and radiomics signature were independent predictors of HCC grade (p < 0.05).

Conclusions

Radiomics signatures may be important for discriminating high-grade and low-grade HCC cases. The combination of the radiomics signatures with clinical factors may be helpful for the preoperative prediction of HCC grade.

Key Points

The radiomics signature based on non-contrast-enhanced MR images was significantly associated with the pathological grade of HCC.

• The radiomics signatures based on T1WI or T2WI images performed similarly at predicting the pathological grade of HCC.

Combining the radiomics signature and clinical factors (including age, sex, tumour size, AFP level, history of hepatitis B, hepatocirrhosis, portal vein tumour thrombosis, portal hypertension and pseudocapsule) may be helpful for the preoperative prediction of HCC grade.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

3D:

Three-dimensional

AFP:

Alpha fetoprotein

AUC:

Area under the curve

CHB:

Chronic hepatitis B

CI:

Confidence interval

DWI:

Diffusion-weighted imaging

GLCM:

Grey-level co-occurrence matrix

GLN:

Grey-level run-length non-uniformity

GLRLM:

Grey-level run-length matrix

HCC:

Hepatocellular carcinoma

LASSO:

Least absolute shrinkage and selection operator

MRI:

Magnetic resonance imaging

MVI:

Microvascular invasion

NSCLC:

Non-small cell lung cancer

OR:

Odds ratio

PACS:

Picture archiving and communication system

ROC:

Receiver operating characteristic

ROI:

Region of interest

T1WI:

T1-weighted imaging

T2WI:

T2-weighted imaging

TE:

Echo time

TR:

Repetition time

References

  1. Njei B, Rotman Y, Ditah I, Lim JK (2015) Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology 61:191–199

    Article  PubMed  Google Scholar 

  2. El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264–1273

    Article  PubMed  Google Scholar 

  3. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108

    Article  PubMed  Google Scholar 

  4. Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S (2005) Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 103:299–306

    Article  PubMed  Google Scholar 

  5. Ng IO, Lai EC, Fan ST, Ng MM, So MK (1995) Prognostic signifcance of pathologic features of hepatocellular carcinoma: a multivariate analysis of 278 patients. Cancer 76:2443–2448

    Article  CAS  PubMed  Google Scholar 

  6. Okusaka T, Okada S, Ueno H et al (2002) Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer 95:1931–1937

    Article  PubMed  Google Scholar 

  7. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236

    Article  PubMed  Google Scholar 

  8. Parmar C, Leijenaar RT, Grossmann P et al (2015) Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer. Sci Rep 5:11044

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kumar V, Gu Y, Basu S et al (2012) Radiomics: the process and the challenges. Magn Reson Imaging 30:1234–1248

    Article  PubMed  PubMed Central  Google Scholar 

  11. Goh V, Ganeshan B, Nathan P, Juttla JK, Vinayan A, Miles KA (2011) Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology 261:165–171

    Article  PubMed  Google Scholar 

  12. Ganeshan B, Goh V, Mandeville HC, Ng QS, Hoskin PJ, Miles KA (2013) Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology 266:326–336

    Article  PubMed  Google Scholar 

  13. Ng F, Ganeshan B, Kozarski R, Miles KA, Goh V (2013) Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 266:177–184

    Article  PubMed  Google Scholar 

  14. Zhang H, Graham CM, Elci O et al (2013) Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with induction chemotherapy. Radiology 269:801–809

    Article  PubMed  Google Scholar 

  15. Yip C, Landau D, Kozarski R, Ganeshan B, Thomas R, Michaelidou A et al (2014) Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with defnitive chemotherapy and radiation therapy. Radiology 270:141–148

    Article  PubMed  Google Scholar 

  16. Liu S, Liu S, Ji C et al (2017) Application of CT texture analysis in predicting histopathological characteristics of gastric cancers. Eur Radiol 27:4951–4959

    Article  PubMed  Google Scholar 

  17. Ganeshan B, Abaleke S, Young RC, Chatwin CR, Miles KA (2010) Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging 10:137–143

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164

    Article  CAS  PubMed  Google Scholar 

  19. Liang CS, Huang YQ, He L et al (2016) The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer. Oncotarget 7:31401–31412

    PubMed  PubMed Central  Google Scholar 

  20. Ayuso C, Rimola J, Garcia-Criado A (2012) Imaging of HCC. Abdom Imaging 37:215–230

    Article  PubMed  Google Scholar 

  21. Nasu K, Kuroki Y, Tsukamoto T, Nakajima H, Mori K, Minami M (2009) Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. AJR Am J Roentgenol 193:438–444

    Article  PubMed  Google Scholar 

  22. Nishie A, Tajima T, Asayama Y et al (2011) Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma. Eur J Radiol 80:e29–e33

    Article  PubMed  Google Scholar 

  23. Kogita S, Imai Y, Okada M et al (2010) Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol 20:2405–2413

    Article  PubMed  Google Scholar 

  24. Zhou W, Zhang LJ, Wang KX et al (2017) Malignancy characterization of hepatocellular carcinomas based on texture analysis of contrast-enhanced MR images. J Magn Reson Imaging 45:1476–1484

    Article  PubMed  Google Scholar 

  25. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer 7:462–503

    Article  CAS  PubMed  Google Scholar 

  26. Coroller TP, Grossmann P, Hou Y et al (2015) CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma. Radiother Oncol 114:345–350

    Article  PubMed  PubMed Central  Google Scholar 

  27. Leijenaar RT, Carvalho S, Hoebers FJ et al (2015) External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncol 54:1423–1429

    Article  CAS  PubMed  Google Scholar 

  28. Zhou L, Rui JA, Zhou WX, Wang SB, Chen SG, Qu Q (2017) Edmondson-Steiner grade: a crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasion. Pathol Res Pract 213:824–830

    Article  PubMed  Google Scholar 

  29. Chung JW, Jang ES, Kim J et al (2017) Development of a nomogram for screening of hepatitis B virusassociated hepatocellular carcinoma. Oncotarget 8:106499–106510

    PubMed  PubMed Central  Google Scholar 

  30. Bai DS, Zhang C, Chen P, Jin SJ, Jiang GQ (2017) The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma. Sci Rep 7:12870

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dapeng Shi.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Dapeng Shi.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was obtained from all subjects (patients) in this study.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• Retrospective

• Diagnostic or prognostic study

• Performed at one institution

Electronic supplementary material

ESM 1

(DOC 567 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, M., Tan, H., Gao, F. et al. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature. Eur Radiol 29, 2802–2811 (2019). https://doi.org/10.1007/s00330-018-5787-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-018-5787-2

Keywords

Navigation